药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Colistin
9-(N-methyl-L-isoleucine)-cyclosporin A
The risk or severity of adverse effects can be increased when Idarubicin is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Colistin
Hypericin
The risk or severity of adverse effects can be increased when Idarubicin is combined with Hypericin.
Colistin
Cortivazol
The risk or severity of adverse effects can be increased when Idarubicin is combined with Cortivazol.
Colistin
Acteoside
The risk or severity of adverse effects can be increased when Idarubicin is combined with Acteoside.
Colistin
Deoxyspergualin
The risk or severity of adverse effects can be increased when Idarubicin is combined with Deoxyspergualin.
Colistin
Doxifluridine
The risk or severity of adverse effects can be increased when Idarubicin is combined with Doxifluridine.
Colistin
Trofosfamide
The risk or severity of adverse effects can be increased when Idarubicin is combined with Trofosfamide.
Colistin
Cepeginterferon alfa-2B
The risk or severity of adverse effects can be increased when Idarubicin is combined with Cepeginterferon alfa-2B.
Colistin
Gusperimus
The risk or severity of adverse effects can be increased when Idarubicin is combined with Gusperimus.
Colistin
Mizoribine
The risk or severity of adverse effects can be increased when Idarubicin is combined with Mizoribine.
Colistin
Ozanimod
The risk or severity of adverse effects can be increased when Idarubicin is combined with Ozanimod.
Colistin
Triptolide
The risk or severity of adverse effects can be increased when Idarubicin is combined with Triptolide.
Colistin
Deflazacort
The risk or severity of adverse effects can be increased when Idarubicin is combined with Deflazacort.
Colistin
Guselkumab
The risk or severity of adverse effects can be increased when Idarubicin is combined with Guselkumab.
Colistin
Baricitinib
The risk or severity of adverse effects can be increased when Idarubicin is combined with Baricitinib.
Colistin
Sirukumab
The risk or severity of adverse effects can be increased when Idarubicin is combined with Sirukumab.
Colistin
Brodalumab
The risk or severity of adverse effects can be increased when Idarubicin is combined with Brodalumab.
Colistin
Sarilumab
The risk or severity of adverse effects can be increased when Idarubicin is combined with Sarilumab.
Colistin
Peficitinib
The risk or severity of adverse effects can be increased when Idarubicin is combined with Peficitinib.
Colistin
Voclosporin
The risk or severity of adverse effects can be increased when Idarubicin is combined with Voclosporin.